Literature DB >> 11117562

Fatty infiltration of liver in hyperlipidemic patients.

N Assy1, K Kaita, D Mymin, C Levy, B Rosser, G Minuk.   

Abstract

Hyperlipidemia is a known risk factor for fatty infiltration of the liver, a condition that can progress to cirrhosis and liver failure. The objectives of this study were to document the prevalence of fatty infiltration in the livers of hyperlipidemic patients and to identify the predictor variables associated with this condition. Over an 18-month recruitment period, clinical, biochemical, and radiologic assessments were performed in a cross-sectional manner in 95 adult patients referred to an urban hospital-based lipid clinic for evaluation and management of hyperlipidemia. The mean (+/-SD) age of the patients was 55 +/- 13 years. Forty-eight (51%) were male. Fifty-two patients (55%) had hypercholesterolemia, 25 (26%) severe hypertriglyceridemia, 14 (15%) mixed hyperlipidemia, and 4 (4%) moderate hypertriglyceridemia. Obesity and diabetes were present in 36 (38%) and 12 (12%) of cases, respectively. A total of 61 (64%) patients had elevated liver enzyme tests. The most common enzyme abnormalities were an elevated serum ALT in 45 (47%) and GGT in 43 (45%) of patients. Ultrasound findings revealed diffuse fatty liver in 47 patients (50%), of which 21 cases (22%) were mild, 18 (19%) moderate, and 8 (9%) severe. The majority of patients with hypercholesterolemia [35/52 (67%)] had normal ultrasounds, whereas severe hypertriglyceridemia and mixed hyperlipidemia were frequently associated with radiologic evidence of fatty liver (odds ratios 5.9 and 5.1 respectively, P < 0.01). Independent predictors of fatty liver were; AST (P = 0.001), hyperglycemia (P = 0.02), and age (P = 0.04). In a model incorporating known risk factors for fatty liver, diabetes was the only risk factor other than hypertriglyceridemia that was significantly associated with fatty infiltration. No such effect was seen with age, gender, obesity, or alcohol consumption. In conclusions, the results of this study indicate that ultrasonographic evidence of fatty infiltration of the liver is evident in approximately 50% of patients with hyperlipidemia. Hypertriglyceridemia is the lipid profile most often associated with this condition. Serum AST values, hyperglycemia, and age independently predict the presence of fatty infiltration, while hypertriglyceridemia and diabetes are the only risk factors that significantly increase the risk of fatty infiltration in hyperlipidemic patients.

Entities:  

Mesh:

Year:  2000        PMID: 11117562     DOI: 10.1023/a:1005661516165

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  Paradoxical lack of ultrasound attenuation with gross fatty change in the liver.

Authors:  R J Davies; S H Saverymuttu; M Fallowfield; A E Joseph
Journal:  Clin Radiol       Date:  1991-06       Impact factor: 2.350

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Liver steatosis and liver resection.

Authors:  S Bengmark
Journal:  Digestion       Date:  1969       Impact factor: 3.216

4.  Clinical relevance of abnormal liver findings with ultrasound.

Authors:  A Ochs; R M Rottler; J Schölmerich
Journal:  Hepatogastroenterology       Date:  1994-02

Review 5.  Fatty liver disease in morbid obesity.

Authors:  D J Clain; J H Lefkowitch
Journal:  Gastroenterol Clin North Am       Date:  1987-06       Impact factor: 3.806

6.  Glycosylated haemoglobin and plasma glycoprotein assays by affinity chromatography.

Authors:  D G Willey; M A Rosenthal; S Caldwell
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

7.  Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol.

Authors:  V T Savolainen; K Liesto; A Männikkö; A Penttilä; P J Karhunen
Journal:  Alcohol Clin Exp Res       Date:  1993-10       Impact factor: 3.455

Review 8.  Descriptive epidemiology of body weight and weight change in U.S. adults.

Authors:  D F Williamson
Journal:  Ann Intern Med       Date:  1993-10-01       Impact factor: 25.391

9.  Patients with persistent elevation of aminotransferases: investigation with ultrasonography, radionuclide imaging and liver biopsy.

Authors:  R Hultcrantz; N Gabrielsson
Journal:  J Intern Med       Date:  1993-01       Impact factor: 8.989

10.  Fatty liver hepatitis and cirrhosis in obese patients.

Authors:  M Adler; F Schaffner
Journal:  Am J Med       Date:  1979-11       Impact factor: 4.965

View more
  90 in total

1.  Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey.

Authors:  Lei Shen; Jian-Gao Fan; Yan Shao; Min-De Zeng; Jun-Rong Wang; Guo-Hao Luo; Ji-Qiang Li; Si-Yao Chen
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

2.  Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  Hüseyin Saadettin Uslusoy; Selim Giray Nak; Macit Gülten
Journal:  World J Hepatol       Date:  2011-08-27

3.  Elevated plasma protein C levels correlate with the presence of fatty liver (NASH and NAFLD).

Authors:  N Assy; S Schlesinger; O Hussein
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

4.  SCAP gene polymorphisms decrease the risk of nonalcoholic fatty liver disease in females with metabolic syndrome.

Authors:  Shanshan Sun; Miao Wang; Haiyan Song; Tao Wu; Huafeng Wei; Songhua He; Zhaoguo Ding; Guang Ji
Journal:  J Genet       Date:  2013-12       Impact factor: 1.166

Review 5.  Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease.

Authors:  David E Cohen; Edward A Fisher
Journal:  Semin Liver Dis       Date:  2013-11-12       Impact factor: 6.115

6.  Veratric acid ameliorates hyperlipidemia and oxidative stress in Wistar rats fed an atherogenic diet.

Authors:  Boobalan Raja; Murugesan Saravanakumar; Gopal Sathya
Journal:  Mol Cell Biochem       Date:  2012-03-18       Impact factor: 3.396

7.  Serum biochemical changes in rabbits on a regular diet with and without flax lignan complex following a high-cholesterol diet.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2008

Review 8.  Statins in nonalcoholic fatty liver disease and steatohepatitis: updated review.

Authors:  William Nseir; Mahmud Mahamid
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

Review 9.  Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

Authors:  Ivana Mikolasevic; Lidija Orlic; Neven Franjic; Goran Hauser; Davor Stimac; Sandra Milic
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

10.  Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats.

Authors:  Ying Qin; Ya-ping Tian
Journal:  Lipids Health Dis       Date:  2010-07-26       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.